Valeant CEO Joseph Papa spoke exclusively with CNBC about the state of drug pricing, and his overall strategy for the months ahead.
Valeant CEO Joseph Papa spoke exclusively with CNBC about the state of drug pricing, and his overall strategy for the months ahead.